HIV/AIDS
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
Published in AIDS Weekly, December 15th, 2008
GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced that the launch of its Phase 2a Human Vaccine Trials will take place in twelve sites across North and South America. These trials are conducted in collaboration with The National Institutes of Health (NIH), and the HIV Vaccine Trials Network (HVTN).
"It is of significant importance to report this major development on this very day in which the world commemorates WORLD AIDS DAY. Despite setbacks reported recently with other vaccine trials, our vaccine is progressing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-12-15)
More Articles from AIDS Weekly
- Canadian Medical Association Journal
Canada's supervised injection site is cost-effective - Stanford University Medical Center
Stanford scientists' discovery of virus in lemur could shed light on AIDS - HIV/AIDS
Investigators at Chulalongkorn University zero in on HIV/AIDS - HIV/AIDS
Mary Ann Liebert, Inc. Provides Free Online Journal Access in Recognition of World AIDS Day - HIV/AIDS
Reports outline HIV/AIDS study findings from M.I. Gonzaleztome and colleagues - HIV/AIDS Cancer
New HIV/AIDS cancer research reported from A. Chadburn and co-authors - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
